Researchers from The GRADE Study set out to compare four commonly prescribed medications for managing type 2 diabetes. Their goal was to find out which drugs worked best when used alongside metformin, the standard first-line treatment for this condition.
Managing blood sugar levels is essential for keeping people with type 2 diabetes healthy and reducing complications over time.
The study involved 5,047 adults with type 2 diabetes from diverse racial and ethnic backgrounds. All participants were already taking metformin when they joined. The researchers divided them randomly into four groups, each receiving a different additional medication.
These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and glimepiride increase the body’s insulin production in different ways, while insulin glargine is a long-acting insulin.
Over an average of four years, the researchers monitored how well each drug helped participants maintain their blood sugar levels within the recommended range. They discovered that adding liraglutide or insulin glargine to metformin was the most effective combination.
Participants in these groups spent the longest time with their blood sugar under control. On average, this was about six months longer than those taking sitagliptin, the least effective option. Glimepiride performed slightly better than sitagliptin but was less effective than liraglutide or insulin glargine.
Interestingly, the study found that the treatment results were consistent across all participants, regardless of their age, sex, race, or ethnicity. However, none of the drugs were a perfect solution.
Despite improvements in average blood sugar levels, nearly 75% of participants could not maintain their target levels over the four years. This highlights how challenging it is for many people with type 2 diabetes to keep their blood sugar within the recommended range long-term.
Another key focus of the study was the impact of these treatments on heart health. Cardiovascular disease is a common and serious complication of diabetes. Among the four groups, those taking liraglutide were least likely to develop heart problems during the study, adding another benefit to this medication.
While the study provided valuable insights, the researchers acknowledged that more work is needed. Although liraglutide and insulin glargine proved to be the most effective in maintaining blood sugar levels, no single combination stood out as a clear winner in every way.
This points to the need for even better strategies and treatments to help people with diabetes manage their condition over the long term.
This large-scale study gives doctors and patients more information to guide treatment decisions. Knowing which medications work best alongside metformin can help individuals achieve better blood sugar control and potentially reduce the risk of complications like heart disease.
The findings were published in The New England Journal of Medicine and led by Dr. Henry Burch and colleagues. For anyone managing diabetes, staying informed about advances in treatment and research is crucial.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and what you need to know about avocado and type 2 diabetes.
For more information about diabetes, please see recent studies about how to eat to prevent type 2 diabetes, and 5 vitamins that may prevent complication in diabetes.
Copyright © 2025 Knowridge Science Report. All rights reserved.
